Examining the Promise of Multicancer Early Detection Tests: Takeaways From the ECLIPSE Trial

In this sixth episode of OncChats: Examining the Promise of Multicancer Early Detection Tests, Toufic A. Kachaamy, MD, Madappa Kundranda, MD, PhD, and Niloy Jewel J. Samadder, MD, discuss important takeaways from the ECLIPSE study (NCT04136002), which evaluated a cell-free DNA blood-based test for colorectal cancer in an average-risk population.

Related Keywords

Niloy Jewelj Samadder ,Toufica Kachaamy ,Madappa Kundranda , ,Multicancer Early Detection Tests ,Niloy Jewel ,Disease Week ,Digestive Disease Week ,Oncchats ,Onclive ,Precision Medicine ,Mayo Clinic ,Banner Md Anderson Cancer Center ,City Of Hope ,Mced ,Cancer Screening ,Eclipse Trial ,D ,Phd ,Cell Free Dna Blood Based Test ,Colorectal Cancer ,Crc ,Colonoscopy ,Dna ,